Florence Baum
Family · Aventura, FLNPI 1609189828
Payments from drug & device makers
Across 211 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$907
- AstraZeneca$552
- Mylan Specialty L.p.$377
- Mallinckrodt Hospital Products Inc.$274
- Novo Nordisk$245
- Sanofi$240
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 56 | $907 |
| AstraZeneca | 29 | $552 |
| Mylan Specialty L.p. | 15 | $377 |
| Mallinckrodt Hospital Products Inc. | 14 | $274 |
| Novo Nordisk | 13 | $245 |
| Sanofi | 10 | $240 |
| Boehringer Ingelheim | 8 | $191 |
| ANI Pharmaceuticals, Inc. | 5 | $134 |
| Pfizer | 6 | $125 |
| Astellas Pharma US Inc | 4 | $91 |
| Exact Sciences | 4 | $77 |
| Johnson & Johnson | 4 | $77 |
| Amgen | 4 | $74 |
| Abbott | 3 | $64 |
| Advanced Respiratory, Inc | 3 | $64 |
| Boston Scientific | 2 | $60 |
| Phadia US Inc. | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| Insightec,inc | 2 | $33 |
| Gilead | 1 | $31 |
| VBI Vaccine (delaware) Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Merck | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Bayer | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Pulmonx Corporation | 1 | $16 |
| United Therapeutics Corporation | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$4,135 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $55,874 |
| MounjaroTirzepatide | 12 | $16,942 |
| OzempicSemaglutide | 11 | $10,389 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,971 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $3,935 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,298 |
| Ventolin HfaAlbuterol Sulfate | 15 | $849 |
| Azelastine Hcl | 17 | $419 |
| Levothyroxine Sodium | 33 | $396 |
| Rosuvastatin Calcium | 23 | $374 |
| Gabapentin | 15 | $345 |
| Montelukast Sodium | 49 | $316 |
| Omeprazole | 21 | $283 |
| Atorvastatin Calcium | 32 | $275 |
| Amlodipine Besylate | 39 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $907 | $55,87475 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $552 | $13,90632 claims |
| Novo NordiskOzempic | $245 | $10,38911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Aventura
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.